Bonaccorso Angela, Pellitteri Rosalia, Ruozi Barbara, Puglia Carmelo, Santonocito Debora, Pignatello Rosario, Musumeci Teresa
Department of Drug Sciences, University of Catania, V.le Andrea Doria, 6, 95125 Catania, Italy.
Institute for Biomedical Research and Innovation, National Research Council, Via Paolo Gaifami 18, 95126 Catania, Italy.
Nanomaterials (Basel). 2021 Jan 10;11(1):159. doi: 10.3390/nano11010159.
Curcumin (Cur) shows anti-inflammatory and antioxidant effects on central nervous system diseases. The aim of this study was to develop Cur-loaded polymeric and lipid nanoparticles for intranasal delivery to enhance its stability and increase antioxidant effect on olfactory ensheathing cells (OECs).
The nanosuspensions were subjected to physico-chemical and technological evaluation through photon correlation spectroscopy (PCS), differential scanning calorimetry (DSC) and UV-spectrophotometry. The cytotoxicity studies of nanosuspensions were carried out on OECs. A viability test was performed after 24 h of exposure of OECs to unloaded and curcumin-loaded nanosuspensions. The potential protective effect of Cur was assessed on hypoxic OECs cells. Uptake studies were performed on the same cell cultures. Thermal analysis was performed to evaluate potential interaction of Cur with a 1,2-Dimyristoyl--glycero-3-phosphocholine (DMPC) biomembrane model.
PCS analysis indicated that lipid and polymeric nanosuspensions showed a mean size of 127.10 and 338.20 nm, respectively, high homogeneity and negative zeta potential. Incorporation of Cur into both nanocarriers increased drug stability up to 135 days in cryoprotected freeze-dried nanosuspensions. Cell viability was improved when hypoxic OECs were treated with Cur-loaded polymeric and lipid nanosuspensions compared with the control.
Both nanocarriers could improve the stability of Cur as demonstrated by technological studies. Biological studies revealed that both nanocarriers could be used to deliver Cur by intranasal administration for brain targeting.
姜黄素(Cur)对中枢神经系统疾病具有抗炎和抗氧化作用。本研究的目的是开发用于鼻内给药的载姜黄素聚合物和脂质纳米颗粒,以提高其稳定性并增强对嗅鞘细胞(OECs)的抗氧化作用。
通过光子相关光谱法(PCS)、差示扫描量热法(DSC)和紫外分光光度法对纳米混悬液进行物理化学和工艺评估。在OECs上进行纳米混悬液的细胞毒性研究。将OECs暴露于未载药和载姜黄素的纳米混悬液24小时后进行活力测试。评估姜黄素对缺氧OECs细胞的潜在保护作用。在相同的细胞培养物上进行摄取研究。进行热分析以评估姜黄素与1,2-二肉豆蔻酰-sn-甘油-3-磷酸胆碱(DMPC)生物膜模型的潜在相互作用。
PCS分析表明,脂质和聚合物纳米混悬液的平均粒径分别为127.10和338.20 nm,具有高均一性和负zeta电位。在冷冻保护的冻干纳米混悬液中,将姜黄素掺入两种纳米载体中可使药物稳定性提高至135天。与对照组相比,用载姜黄素的聚合物和脂质纳米混悬液处理缺氧OECs时细胞活力得到改善。
技术研究表明,两种纳米载体均可提高姜黄素的稳定性。生物学研究表明,两种纳米载体均可用于通过鼻内给药递送姜黄素以实现脑靶向。